DRUG · Unmapped registry intervention
18F-PSMA-1007
Find medicine records ·
Find other trials using this name
Clinical trial
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
NCT05422105
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedDiagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
Design: OBSERVATIONAL · Status: SUSPENDED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Prostate Neoplasmverified · MONDO: prostate neoplasm
Interventions
18F-PSMA-1007DRUG
Sponsors & collaborators
Primo Biotechnology Co., Ltdlead sponsor
ABX advanced biochemical compounds GmbHcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05422105 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.